Clinical Trial Update: EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis [Phase 2]

View source ↗

Summary

A Phase 2 trial of Extracorporeal Photopheresis (EPIC) for immune-related colitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune-related Colitis

Drugs mentioned

• Extracorporeal Photopheresis

Snippet

Sponsor: Therakos LLC | Conditions: Immune-related Colitis | Phase 2 | Status: WITHDRAWN